Breast-specific gamma imaging developer Dilon Diagnostics has signed a three-year sales agreement with mammography information systems developer PenRad Technologies.
Under the terms of the pact, Dilon's portfolio now will include the PenRad mammography information system (MIS) and also Volpara, a quantitative breast density assessment tool designed to convert a qualitative breast x-ray image into quantitative data.Dilon inks sales pact with PenRad
Latest in Breast
Sectra inks 5-year deal with MaineGeneral Health
October 15, 2024